Novartis considers sale of ophthalmology, respiratory units: Reports

Swiss drugmaker Novartis is considering selling its ophthalmology and respiratory units, Bloomberg reported citing people familiar with the matter. The company is seeking to raise money from the possible sale of the assets to invest in cutting-edge medicines, the report said. Any sale of the ophthalmology and respiratory businesses is likely to begin in 2023, the report added.